Objectives: To investigate the population structure of Enterococcus faecium causing bloodstream infections (BSIs) in a tertiary Spanish hospital with low glycopeptide resistance, and to enhance our knowledge of the dynamics of emergence and spread of high-risk clonal complexes.
Introduction
Enterococci, especially Enterococcus faecalis and Enterococcus faecium, have long been recognized as important causes of human infections. 1, 2 These species currently represent the second or third leading cause of healthcare-associated bacteraemia in American and European hospitals, 1, 3 in contrast with studies from the 1980s that ranked enterococci as the sixth most common hospital opportunistic pathogens. 4 Most enterococcal nosocomial infections were caused by E. faecalis up to the early 1990s when a steady increase in the number of cases of ampicillin-resistant E. faecium (AREfm; often also vancomycin resistant) started to be detected. 2,4 -6 At that time, some studies also reported a change in the ratio of E. faecalis:E. faecium causing disease from 10:1 before 1990 to 3:1 in the late 1990s, 5, 7 documenting a new challenge in the management of the enterococcal infections.
With a few exceptions, most of the available information regarding E. faecium population structure is based on crosssectional targeted studies, often focused on VRE isolates. 8 -11 The majority of E. faecium causing nosocomial infections belong to the major hospital lineages 17, 18 and 78 (originating from ST17, ST18 and ST78, respectively) that have progressively acquired traits coding for antibiotic resistance and traits that provide colonization advantages. 11 Although isolates of these lineages are now predominant in hospitals worldwide, temporal and spatial differences have been observed within and between different geographical areas. 10 -13 Available information is mostly based on eBURST analysis of data obtained by MLST, 14, 15 but this approach does not reliably establish evolutionary descent patterns for highly recombinant species such as E. faecium. The recent application of Bayesian Analysis of Population Structure (BAPS) to E. faecium seems to accurately establish relatedness among populations within this species. 11, 12 Other approaches such as cgMLST have been recently developed, but demand full genome sequencing that is often not affordable for laboratories of clinical microbiology. 16 Long-term detailed studies are certainly needed to understand the epidemiological basis of changes in the population dynamics of this species in the hospital setting. The objective of this work was to comprehensively analyse the population structure of E. faecium strains recovered from BSIs (by using PFGE, MLST tools to feed goeBURST and BAPS analysis) under the light of epidemiological patients' data. A distinctive trait of our study is that our geographical area still remains relatively free of VRE.
Methods

Ethics
This observational study was approved by the local ethics committee.
Epidemiological data and sampling of E. faecium isolates
A total of 21 695 positive blood cultures were detected in Hospital Universitario Ramó n y Cajal (HRyC) between January of 1996 and May of 2015. HRyC is a tertiary care public hospital with 1155 beds that provides specialized attention to a population size of 600 000 habitants in the Northern area of Madrid (Spain). Epidemiology of isolates up to 2002 was previously analysed elsewhere. 3, 17 Of the total number of microorganisms isolated from positive blood cultures, 1816 were identified as enterococci (8.4%), of which 531 were E. faecium (2.4%). To avoid duplications, only one positive sample per bloodstream infection (BSI) was considered. E. faecium isolates obtained from the same patient at different time periods [more than 1 month apart (n¼6 patients)] were also included. Using this criterion we identified 403 episodes of E. faecium BSIs between 1996 and 2015 corresponding to 395 patients. Due to the changes in the Laboratory Information Software used in HRyC's Microbiology Department in 1996, data of patients from 1995 were not available for analysis. In spite of the lack of patient data, we were able to recover all 10 E. faecium BSI isolates collected in 1995 making the total number of E. faecium isolates analysed 413 (405 patients).
E. faecium BSIs were classified as community acquired if the sample was obtained within the first 48 h after hospital admission and the patients had no history of previous hospitalization or antibiotic therapy in the 6 months previous to the positive blood culture. Otherwise, we considered that the BSIs were acquired in the hospital setting. 12 
Bacterial identification and antibiotic susceptibility
Bacterial identification was performed using WIDER, MICROSCAN (Francisco Soria Melguizo, Madrid, Spain) and during the last 5 years MALDI-TOF MS (Bruker, Bellerica, MA, USA). Susceptibility to 12 antibiotics was determined using WIDER and MICROSCAN standard panels and also by the agar dilution method (Oxoid, Basingstoke, UK) according to CLSI guidelines. 18 
E. faecium clonal relationship
Clonal relationship was established by PFGE and MLST as previously described.
14,17 E. faecium population structure was further characterized using the BAPS scheme previously described, 11, 12 which was updated for this article in order to include the new STs described in this work (making a total of 1115 STs); MLST database was updated in February 2016. See the supplementary text available as Supplementary data at JAC Online.
Presence of putative virulence factors and IS16
The presence of known E. faecium putative virulence genes esp (encoding enterococcal surface protein) and hyl Efm (encoding glycosyl hydrolase) were investigated by PCR and further sequencing. The presence of IS16, a marker of strains involved in hospital-associated infections, was carried out as previously described.
19,20
Statistical analysis
Statistical significance was calculated using the x 2 test using RStudio; P values ,0.05 were considered to be statistically significant. 21 
Results
The rising trend in enterococcal BSIs is due to the increase in the number of MDR E. faecium Figure 1 and Figure S1 (available as Supplementary data at JAC Online) represent the BSI metrics in our institution (total cases and incidence of BSIs caused by Enterococcus spp., E. faecium and E. faecalis). The data presented correspond to the years between 1996 and 2014 as patient records from 1995 were unavailable and note that we only analysed isolates collected for the first 6 months of 2015. Despite some fluctuations, the total incidence of BSIs in our hospital showed a significant decrease from 1996 to 2014 (39‰ versus 30‰ of attended patients, P, 0.001). However, we should take into account the decrease in the number of positive blood cultures that was recorded from 2009 onwards. This decrease was coincidental with a better adherence to the rule that each culture flask should be extracted from different arms in order to reduce false positives due to skin microbiota contamination.
In this scenario, the incidence of Enterococcus spp. BSIs increased from 2.3‰ of attended patients (n¼68, 5.8% of 1170 BSIs) to 3.0‰ of attended patients (n¼98, 9.5% of 1035 BSIs) in 2014. Such an increase paralleled that of E. faecium BSIs episodes in the same period, ranging from 0.33‰ of attended patients (n ¼ 10, 0.85% of 1170 BSIs) to 1.3‰ of attended patients (n¼ 42, 4.6% of 1035 BSIs). Because the incidence of E. faecalis BSIs was steadily maintained during the study [1.8‰ of patients (n¼53) in 1996 and 1.6‰ of patients (n¼50) in 2014], the ratio of E. faecalis:E. faecium BSIs declined from 5:1 in 1996 to 1:1 in 2014. Most of the E. faecium BSI strains were resistant to ampicillin, levofloxacin, ciprofloxacin and erythromycin, and showed highlevel resistance (HLR) to streptomycin. Ciprofloxacin and erythromycin were the only antimicrobials to which early isolates were resistant (Figures 1 and 2) .
The number of E. faecium involved BSIs increased with the age of the patients (average, 62.7+20.0 years; range, 0 -95 years old) being mostly associated with the elderly (≥60 years, 257/405, P, 0.0001) compared with adults (20 - Figure S2 and Table S1 ).
E. faecium was isolated with other microorganisms in 32.7% of the E. faecium blood cultures. The most commonly species identified with E. faecium were: Escherichia coli (n ¼ 36), Staphylococcus (n ¼ 30), Klebsiella (n ¼ 15), other Enterococcus (n¼ 13), Pseudomonas (n¼ 10), Streptococcus (n¼ 6), Morganella (n¼ 5) and yeasts (n ¼11).
Genotypic heterogeneity of E. faecium BSI isolates: dominance of a few lineages
The 413 E. faecium BSI isolates were assigned to 53 STs, 12 of these STs (22.6%) being described here for the first time (to our knowledge). Most STs (86.0%) corresponded to major hospital-associated lineages 78 (n ¼ 154, ST80, ST117, ST203, ST442, ST677 and ST1115), 17 (n ¼ 119, ST16, ST17, ST63, ST103 and ST578) and 18 (n ¼ 82, ST18 and ST262) originating from ST17, ST78 and ST18, respectively. 11 Other STs less frequently detected are shown in Figure 3 .
The 53 STs were partitioned into six BAPS groups (supplementary text and Figure S2 ). The most prevalent were BAPS 3 (54.3%) and BAPS 2 (40.8%), whereas BAPS 1, BAPS 7, BAPS 6 and BAPS 9 (3.2%, 1.0%, 0.5% and 0.2%, respectively) were sporadically detected ( Figure S3 ). 
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Enterococcus faecium BSI dynamics JAC BAPS 3 comprises both AREfm (90.5%) and ampicillinsusceptible E. faecium (ASEfm; 9.5%) isolates, some strains being recovered for extended periods of time. BAPS 3.3a1 (37.1%; e.g. lineage 18) and BAPS 3.3a2 (53.8%; e.g. lineage 17) were often AREfm strains 22 that contained IS16 (97.5% and 92.8%, respectively) and putative virulence traits, such as hyl Efm (50.0% and 72.3%, respectively) or esp (37.8% and 66.4%, respectively). These lineages accounted for 52.4% of E. faecium BSIs in elderly patients at medical wards. The other BAPS 3 subgroups, namely BAPS 3.3b (2.3%, 3 STs; e.g. ST102), BAPS 3.1 (5.9%, 6 STs; e.g. ST22) and BAPS 3.2 (0.9%, 2 STs), comprise mostly ASEfm corresponding to diverse STs and PFGE types. They were susceptible to the majority of antibiotics tested and only sporadically harboured putative virulence genes or IS16 (Figures 3 and 4) . BAPS 2 also comprised both AREfm (91.0%) and ASEfm (9.0%) isolates. While ASEfm were recovered during the whole study period, most of AREfm isolates were only detected since 2006. Within BAPS 2, subgroup BAPS 2.1a was predominant (89.8%). It includes the major hospital-associated lineage 78 and comprises MDR isolates, enriched in esp (59.7%) and IS16 (91.2%), which often harbour hyl Efm (42.3%). Isolates of BAPS subgroups 2.1b, 2.3a and 2.3b were scarcely identified in our sample (Figures 3 and 4) . BAPS 1 (BAPS 1.2, BAPS 1.5 and BAPS 1.1, 10 STs), one of the most abundant enterococcal groups among colonized healthy individuals, 12 was only sporadically represented in the BSIs in this study and most isolates being susceptible to antibiotics and/or lacking virulence genes and IS16 (Figures 3 and 4) .
Clonal dynamics of E. faecium causing BSIs
Figures 3 and 5 show the long-term clonal dynamics of E. faecium in our institution. We identified several apparent 'clonal waves' of E. faecium. Genetically diverse ASEfm (STs of BAPS 1, BAPS 3.1, BAPS 3.3b), which commonly colonized non-hospitalized persons in our setting, 12 and also AREfm ST18 isolates (PFGE types AREF-A and AREF-D) were recovered throughout the period of study, particularly from 1995 to 2006. 
Discussion
This work constitutes one of the few long-term studies addressing the occurrence of enterococcal infections in the hospital setting and documents a remarkable increase in E faecium BSIs in the last decade in our hospital. The coincidental increase in the number of BSIs caused by E. faecium (and the number of cancer patients with documented episodes of such infections), with the emergence of major human AREfm lineages in our hospital during the 2006-15 period, can also be indirectly inferred from the data of multicentre studies, 1,24 studies confined to a single institution 13 or surveys focused on VRE, MDR isolates or particular groups of patients (e.g. cancer patients). 9 Previous antibiotic treatment is traditionally considered as one of the main risk factors for acquisition of BSIs by enterococci. 25 Since the mid-2000s, therapy with broad-spectrum b-lactams (including carbapenems) or levofloxacin, to treat or prevent infections caused by MDR Enterobacteriaceae in onco-haematological patients with febrile neutropenia, 9 has been implemented in many hospitals, including ours 26 and is now recognized as one of the main risk factors for acquisition of BSIs by antibiotic-resistant Gram-positive organisms including E. faecium. 9,26 -28 Cross-transmission of bacterial strains between inpatients has contributed to the increase in nosocomial infections caused by antibiotic-resistant E. faecium, 26, 29 as reflected by the high number of hospital outbreaks reported in recent decades. However, the diversity of populations of a given species in the gut flora, eventually changing in frequency with antibiotic exposure and age, comes to light in this and other recent works. 12, 30, 31 The recovery of highly diverse E. faecium (six BAPS groups associated with both commensal antibiotic susceptible isolates and pathogenic antibiotic-resistant isolates) from blood cultures, 12 suggested 
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Enterococcus faecium BSI dynamics JAC that bacterial translocation and invasive processes of stochastic nature can be enhanced when an increase in the populations size occurs (classically known as 'colonization pressure'). 32 The predominance of ST17, ST18 and ST78 isolates in this and other studies 33, 34 suggested that they established as part of the patients' intestinal microbiota. 12 This hypothesis would be in agreement with a recent study that highlighted the relevance of host's microbial inheritance even at strain level. 30 Although WGS might represent an option to unequivocally elucidate the clonal relatedness among isolates, the frequent horizontal gene transfer (HGT) events that happen in E. faecium and the scarcity of reference genomes makes it difficult to choose an optimal approach to analyse dynamics. 23 At a first glance, the clonal 'waves' of different STs through time (shifts from ST17 and ST18 to ST78) and space (local differences in the occurrence of STs) 10, 11 indicates the successive selection, expansion and evolution of certain clones, following hospital microepidemics. 2 Besides clonal expansion of specific strains, an increasingly high intra-clonal diversification of E. faecium strains belonging to 17, 18 and 78 lineages, was found in this and also in other works. 8 The frequent heterogeneity of populations of commensal organisms, designated as 'clouds' of clones, can be interpreted as providing a global adaptive benefit for the overall species, enhanced by HGT events. 35, 36 HGT among co-occurring related clones assuring a common pool of adaptive plasmids and transferable elements interacting between clones and clonal variants is increasingly documented, including isolates analysed in this work. 23, 37, 38 In summary, our results document that a number of clones derived from ST17 and ST18 AREfm lineages endowed with colonization factors were continuously isolated during the last two decades in BSIs in our hospital, which can only be explained by a continuous and dense colonization (favouring both invasion and cross-transmission) of hospital patients; during the last decade clones derived from ST78 lineage were added to these high-risk clones. High-density colonization by these clones is probably enhanced in elderly patients by heavy and prolonged antibiotic exposure, particularly in oncological patients. This high-risk colonization constitutes an emerging problem that is becoming a serious antibiotic resistance threat comparable to that of VRE. 38 Maybe preventive anti-colonization interventions to limit that problem could be envisaged in the future. Further detailed longitudinal studies of changes in the E. faecium population structure in hospitalized and non-hospitalized populations, including healthy individuals, will be required to associate different clones and subclones with particular types of hosts and drug exposures and to understand the relative risks for human health of the different enterococcal populations. 
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